BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14627686)

  • 1. Association of INPP1, PIK3CG, and TSC2 gene variants with autistic disorder: implications for phosphatidylinositol signalling in autism.
    Serajee FJ; Nabi R; Zhong H; Mahbubul Huq AH
    J Med Genet; 2003 Nov; 40(11):e119. PubMed ID: 14627686
    [No Abstract]   [Full Text] [Related]  

  • 2. Leading-edge research: PtdIns(3,4,5)P3 and directed migration.
    Franca-Koh J; Kamimura Y; Devreotes PN
    Nat Cell Biol; 2007 Jan; 9(1):15-7. PubMed ID: 17199126
    [No Abstract]   [Full Text] [Related]  

  • 3. Signalling through phosphoinositide 3-kinases: the lipids take centre stage.
    Leevers SJ; Vanhaesebroeck B; Waterfield MD
    Curr Opin Cell Biol; 1999 Apr; 11(2):219-25. PubMed ID: 10209156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoinositide signaling in urological disease.
    Theodorescu D
    J Urol; 2003 Jun; 169(6):2394-6. PubMed ID: 12771804
    [No Abstract]   [Full Text] [Related]  

  • 5. [Involvement of phosphoinositide 3-kinases and phosphoinositide phosphatases in immune responses, glucose metabolism and tumorigenesis].
    Sasaki T; Sasaki J; Suzuki A; Penninger JM
    Tanpakushitsu Kakusan Koso; 2001 Sep; 46(12):1820-9. PubMed ID: 11552264
    [No Abstract]   [Full Text] [Related]  

  • 6. Phosphatidylinositol 3-kinase, phosphoinositides and apoptosis. Polyphosphoinositol phosphatase and apoptosis.
    Sarmay G
    Subcell Biochem; 2002; 36():309-33. PubMed ID: 12037988
    [No Abstract]   [Full Text] [Related]  

  • 7. High-throughput sequencing of mGluR signaling pathway genes reveals enrichment of rare variants in autism.
    Kelleher RJ; Geigenmüller U; Hovhannisyan H; Trautman E; Pinard R; Rathmell B; Carpenter R; Margulies D
    PLoS One; 2012; 7(4):e35003. PubMed ID: 22558107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Receptor tyrosine kinases (c-kit, c-fmns, Flt-3, Tie2, etc.)].
    Yoshimura A; Sanada M; Mashima R
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():207-14. PubMed ID: 15861658
    [No Abstract]   [Full Text] [Related]  

  • 9. Phosphatidylinositol signalling reactions.
    Zhang X; Majerus PW
    Semin Cell Dev Biol; 1998 Apr; 9(2):153-60. PubMed ID: 9599410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytokine receptors and signal transduction].
    Nakajima H; Kitamura T
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():178-86. PubMed ID: 15861654
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
    Oudit GY; Sun H; Kerfant BG; Crackower MA; Penninger JM; Backx PH
    J Mol Cell Cardiol; 2004 Aug; 37(2):449-71. PubMed ID: 15276015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic abnormalities in endometrial cancer].
    Takeshima N; Hirai Y
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():254-8. PubMed ID: 15535246
    [No Abstract]   [Full Text] [Related]  

  • 13. SNP identification, haplotype analysis, and parental origin of mutations in TSC2.
    Roberts PS; Chung J; Jozwiak S; Dabora SL; Franz DN; Thiele EA; Kwiatkowski DJ
    Hum Genet; 2002 Jul; 111(1):96-101. PubMed ID: 12136241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of tryptophan 2,3 dioxygenase gene polymorphism with autism.
    Nabi R; Serajee FJ; Chugani DC; Zhong H; Huq AH
    Am J Med Genet B Neuropsychiatr Genet; 2004 Feb; 125B(1):63-8. PubMed ID: 14755447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Topics on gene abnormality in endometrial cancer].
    Shiozawa T; Konishi I
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():259-63. PubMed ID: 15535247
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression.
    Ma L; Teruya-Feldstein J; Behrendt N; Chen Z; Noda T; Hino O; Cordon-Cardo C; Pandolfi PP
    Genes Dev; 2005 Aug; 19(15):1779-86. PubMed ID: 16027168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2.
    Manning BD; Logsdon MN; Lipovsky AI; Abbott D; Kwiatkowski DJ; Cantley LC
    Genes Dev; 2005 Aug; 19(15):1773-8. PubMed ID: 16027169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
    Paez J; Sellers WR
    Cancer Treat Res; 2003; 115():145-67. PubMed ID: 12613196
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
    Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
    Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between autism and SLC25A12.
    Rabionet R; McCauley JL; Jaworski JM; Ashley-Koch AE; Martin ER; Sutcliffe JS; Haines JL; DeLong GR; Abramson RK; Wright HH; Cuccaro ML; Gilbert JR; Pericak-Vance MA
    Am J Psychiatry; 2006 May; 163(5):929-31. PubMed ID: 16648338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.